Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

SemBioSys Genetics Inc.

SemBioSys Genetics Inc. (SBS.TSX) is a biotechnology company engaged in the development and commercialization of protein pharmaceutical and non-pharmaceutical products. PlatformOur proprietary protein production system addresses major commercialization challenges associated with the production of recombinant proteins; overcoming limitations in scale, capital and production costs. SemBioSys’ proprietary technology harnesses the natural ability of seeds to produce, extract and purify proteins in large quantities and at low cost, while dramatically reducing downstream purification costs. It is unique as the only transgenic technology that addresses protein recovery and purification simultaneously with bulk protein production. SemBioSys’ technology is compatible with simple peptides, polypeptides and complex proteins such as antibodies.


Contact Details:
110, 2985 - 23rd Avenue
Calgary
Nebraska
AB T1Y 7L3
United States of America
Tel:403.250.5424
Fax:403.250.3886
Email:info@sembiosys.com
WWW:

www.sembiosys.com/




Loading...

Recent Publications by SemBioSys Genetics Inc.:

Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds.
The increased incidence of diabetes, coupled with the introduction of...
27th January, 2007
SemBioSys Genetics Inc, 110, 2985-23 Ave NE, Calgary, AB, T1Y 7L3, Canada. Plant Biotechnol J. 2006 Jan;4(1):77-85.
DOI Direct Link
Precise and efficient cleavage of recombinant fusion proteins using mammalian aspartic proteases.
Expression of recombinant proteins as translational fusions is commonly...
3rd July, 2004
SemBioSys Genetics Inc., 110 2985 23rd Avenue NE, Calgary AB T1Y 7L3, Protein Eng. 2003 Oct;16(10):777-83.

Press Releases on SemBioSys Genetics Inc.:

BioPortfolio Logo
SemBioSys announces third quarter 2009 financial and operational results 13th November, 2009 SemBioSys Genetics Inc.
CALGARY, Nov. 13 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture of high-value proteins and oils in plant seeds, today announced its third quarter 2009
SemBioSys enters in non-dilutive financing plan of arrangement 30th October, 2009 SemBioSys Genetics Inc.
TSX symbol: SBS CALGARY, Oct. 30 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. ("SemBioSys") (TSX:SBS) today announced that it has entered into an arrangement agreement in respect of a
SemBioSys enters into commercialization and supply agreement for plant-made chymosin protein 22nd October, 2009 SemBioSys Genetics Inc.
TSX symbol: SBS CALGARY, Oct. 22 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS) today announced that it has entered into an exclusive commercial license agreement with Instituto de
SemBioSys provides an update on Botaneco 21st October, 2009 SemBioSys Genetics Inc.
TSX symbol: SBS CALGARY, Oct. 21 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. ("SemBioSys") (TSX:SBS) today announced that Advitech Inc. ("Advitech") has entered into a
Data for SemBioSys' insulin to be presented at the American Diabetes Association's 69th Scientific Sessions 5th June, 2009 SemBioSys Genetics Inc.
CALGARY, June 5 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture of high-value proteins and oils in plant seeds, today announced that it will present the

BioNews Results for SemBioSys Genetics Inc.:

SemBioSys announces third quarter 2009 financial and operational results
KOTA Territory News:  Nov 14 2009 11:05PM Matching: sembiosys genetics inc
SemBioSys announces third quarter 2009 financial and operational results
KSLA:  Nov 14 2009 7:28AM Matching: sembiosys genetics inc
Third quarter financial results announced by SemBioSys Genetics
News-Medical.Net:  Nov 13 2009 1:15PM Matching: sembiosys genetics inc
SemBioSys announces third quarter 2009 financial and operational results
CNW Telbec:  Nov 13 2009 12:03PM Matching: sembiosys genetics inc
SemBioSys inks pact with Cathedral Energy Services Income Trust for financial arrangement
PharmaBiz:  Nov 3 2009 9:13AM Matching: sembiosys genetics inc
Promote your company here: BioNewsCast - Press Release Distribution

View more SemBioSys Genetics Inc. news.

SemBioSys Genetics Inc. Patents:

US Patent No.Title
7585645 Thioredoxin and thioredoxin reductase containing oil body based products
6582710 Products for topical applications comprising oil bodies
6509453 Oil bodies and associated proteins as affinity matrices
6372234 Products for topical applications comprising oil bodies
6288304 Expression of somatotropin in plant seeds

View more SemBioSys Genetics Inc. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 436 times since April 2007, the link to the organisation's website has been followed 62 times

Recent Search Terms used to find this page: TSX SBS | sembiosys genetics inc. | Sembiosys patent for insulin | .

Search for more companies in Calgary

Search for more companies in Nebraska



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for SemBioSys Genetics Inc.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.